Adding MRI Improves Cost-Effectiveness of Prostate Cancer Active Surveillance
Excerpt from the Article:
In men who have prostate cancer, pairing active surveillance with prostate MRI is a more cost-effective approach to treatment over time than relying on active surveillance, repeated biopsy and prostate-specific antigen (PSA) tests.
These findings, published July 14 in Radiology, come on the heels of additional research that indicates prostate MRI can cut over-diagnosis in half when used for screening. In this new study, investigators from New York University Grossman School of Medicine look at the cost associated with various surveillance strategies, as well as the associated life expectancy.
Click the button below to read the entire Article:
Discover What Sets TrialStat Apart From Ordinary Data Management
Click the image or button below to explore our interactive infographic which illustrates the comprehensive and unique capabilities of the TrialStat eClinical Suite.
Request Your Demo Today!
From rapid database build through database lock, we deliver consistent quality on-time and on-budget. Ready to upgrade your eClinical toolkit?